Immunoglobulin A Antibodies: From Protection to Harmful Roles
Immunological Reviews · 2024-11 · 328 (1) · 171-191
DOI: 10.1111/imr.13424 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunological Reviews, online erschienen am 23.11.2024. Verfasst von Patrick J Gleeson und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Research on Inflammation, Paris Cité University, Paris, France. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Immunity, Mucosal, Immunoglobulin A. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 232 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institut de Médecine et d'Epidémiologie Appliquée, COFECUB, Fondation pour la Recherche Médicale.
Abstract (Originalsprache)
Immunoglobulin A (IgA) is the most abundantly produced antibody in humans. IgA is a unique class of immunoglobulin due to its multiple molecular forms, and a defining difference between the two subclasses: IgA1 has a long hinge‐region that is heavily O‐glycosylated, whereas the IgA2 hinge‐region is shorter but resistant to bacterial proteases prevalent at mucosal sites. IgA is essential for immune homeostasis and education. Mucosal IgA plays a crucial role in maintaining the integrity of the mucosal barrier by immune exclusion of pathobionts while facilitating colonization with certain commensals; a large part of the gut microbiota is coated with IgA. In the circulation, monomeric IgA that has not been engaged by antigen plays a discrete role in dampening inflammatory responses. Protective and harmful roles of IgA have been studied over several decades, but a new understanding of the complex role of this immunoglobulin in health and disease has been provided by recent studies. Here, we discuss the physiological and pathological roles of IgA with a special focus on the gut, kidneys, and autoimmunity. We also discuss new IgA‐based therapeutic approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Research on Inflammation, Paris Cité University, Paris, France.
- INSERM, Paris, France.
- CNRS, Paris, France.
- Inflamex Laboratory of Excellence, Paris, France.
- Nephrology Department, Bichat Hospital, Paris, France.
- Department of Immunology, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, Brazil.
ORCID-Profile: Renato C Monteiro
Förderung
- Institut de Médecine et d'Epidémiologie Appliquée
- COFECUB
- Fondation pour la Recherche Médicale
- Agence Nationale de la Recherche
- Inflamex laboratory of Excellence
- Laboratoire d'Excellence Inflamex
Zitieren
APA
Gleeson, P. J., Camara, N. O. S., Launay, P., Lehuen, A., & Monteiro, R. C. (2024). Immunoglobulin A Antibodies: From Protection to Harmful Roles. Immunological Reviews, 328(1), 171-191. https://doi.org/10.1111/imr.13424
Vancouver
Gleeson PJ, Camara NOS, Launay P, Lehuen A, Monteiro RC. Immunoglobulin A Antibodies: From Protection to Harmful Roles. Immunological Reviews. 2024;328(1):171-191. doi:10.1111/imr.13424
BibTeX
@article{Gleeson2024,
author = {Gleeson, Patrick J and Camara, Niels O S and Launay, Pierre and Lehuen, Agnès and Monteiro, Renato C},
title = {Immunoglobulin A Antibodies: From Protection to Harmful Roles},
journal = {Immunological Reviews},
year = {2024},
volume = {328},
number = {1},
pages = {171--191},
doi = {10.1111/imr.13424}
}
EUVIMED